Search Results - "Stranne J"

SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer.

Authors: Stranne, J. Brasso, K. Brennhovd, B. et al.

Source: Scandinavian Journal of Urology (Taylor & Francis Ltd). Oct-Dec2018, Vol. 52 Issue 5/6, p313-320. 8p.

Risk of hernia formation after radical prostatectomy: a comparison between open and robot-assisted laparoscopic radical prostatectomy within the prospectively controlled LAPPRO trial.

Authors: Nilsson, H. Stranne, J. Hugosson, J. et al.

Source: Hernia. Feb2022, Vol. 26 Issue 1, p157-164. 8p.

Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey.

Authors: Stranne, J. Axen, E. Franck-Lissbrant, I. et al.

Source: World Journal of Urology. Jun2020, Vol. 38 Issue 6, p1397-1411. 15p.

Inguinal hernia is a common complication in lower midline incision surgery.

Authors: Stranne, J. Hugosson, J. Lodding, P.

Source: Hernia. Jun2007, Vol. 11 Issue 3, p247-252. 6p. 3 Charts, 3 Graphs.

Correction: Risk of hernia formation after radical prostatectomy: a comparison between open and robot-assisted laparoscopic radical prostatectomy within the prospectively controlled LAPPRO trial.

Authors: Nilsson, H. Stranne, J. Hugosson, J. et al.

Source: Hernia. Mar2022, p1-1. 1p.

23 THE ABSENCE OF LUTS IN MEN WITH A PSA ≥ 3.0 NG/ ML IS AN INDEPENDENT RISK FACTOR FOR PROSTATE CANCER

Authors: Frånlund, M. Stranne, J. Aus, G. et al.

Source: European Urology Supplements. Mar2011, Vol. 10 Issue 2, p35-36. 2p.

POD-10.07: Components of the Metabolic Syndrome Are Risk Factors for LUTS in the Swedish Male Population

Authors: Stranne, J. Damber, J. Fall, M. et al.

Source: Urology. Oct2009 Supplement, Vol. 74, pS32-S32. 1p.

UP-02.49: Prophylactic per-operative narrowing of the internal inguinal annulus at radical retropubic prostatectomy decreases the risk of post-operative inguinal hernia

Authors: Stranne, J. Aus, G. Bergdahl, S. et al.

Source: Urology. Nov2006 Supplement, Vol. 68, p267-267. 1p.

61 - Long term outcomes for men in a screening trial with an initial benign biopsy: A population-based cohort.

Authors: Arnsrud Godtman, R. Palmstedt, E. Stranne, J. et al.

Source: European Urology Supplements. Mar2018, Vol. 17 Issue 2, pe87-e88. 1p.

A0895 - Prostate cancer incidence and mortality after stop age in the Göteborg branch of ERSPC.

Authors: Hugosson, J. Frånlund, M. Arnsrud Godtman, R. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS1275-S1276. 2p.

850 A comparison of the effectiveness of organised versus opportunistic screening measured as number need to invite (NNI) and number needed to diagnose (NND). Results from the Gothenburg randomised population-based prostate cancer screening trial.

Authors: Godtman, R. Holmberg, E. Stranne, J. et al.

Source: European Urology Supplements. Apr2014, Vol. 13 Issue 1, pe850-e850. 1p.

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

Authors: Hugosson J Carlsson S Aus G et al.

Source: Lancet Oncology. Aug2010, Vol. 11 Issue 8, p725-732. 8p.

A1161 - Lymph swelling after radical prostatectomy and pelvic lymph node dissection.

Authors: Carlsson, S.G. Bottai, M. Lantz, A. et al.

Source: European Urology. 2022 Supplement 1, Vol. 81, pS1716-S1717. 2p.

A0609 - Complications after transrectal ultrasound guided biopsies in screening for prostate cancer with PSA followed by MRI – results from the Göteborg prostate cancer screening 2 trial.

Authors: Kohestani, K. Arnsrud Godtman, R. Assadi, A. et al.

Source: European Urology. 2022 Supplement 1, Vol. 81, pS912-S913. 2p.

A0131 - Fosfomycin versus Ciprofloxacin as transrectal prostatebiopsy antibiotic prophylaxis – an open randomized controlled multicenter drug trial.

Authors: Andreasson, A. Hällgren, A. Georgeoulas, P. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS180-S180. 1p.

1125 - Prostate cancer risk after stop-age in men participating in a long-term screening program: Results from the Gothenburg randomized population-based prostate-cancer screening trial.

Authors: Frånlund, Månsson M. Arnsrud Godtman, R. Grenabo Bergdahl, A. et al.

Source: European Urology Supplements. Mar2019, Vol. 18 Issue 1, pe1521-e1522. 2p.

P228 - Erectile function and oncologic outcomes following open retropubic and robot-assisted radical prostatectomy: Results from the laparoscopic prostatectomy robot open trial.

Authors: Pini, G. Sooriakumaran, P. Nyberg, T. et al.

Source: European Urology Supplements. Sep2018, Vol. 17 Issue 8, p321-322. 2p.

1138 - Multiparametric (mp) MRI or biparametric (bp) MRI when screening for prostate cancer (PC). Results from the Göteborg 2 randomized PC screening study (G2 study).

Authors: Hugosson, J. Wallström, J. Geterud, K. et al.

Source: European Urology Supplements. Mar2019, Vol. 18 Issue 1, pe1538-e1538. 1p.

1094 Outcome following surveillance of men with screen-detected prostate cancer. Results from the Gothenburg randomised population-based prostate cancer screening trial

Authors: Godtman, R. Arnsrud Holmberg, E. Khatami, A. et al.

Source: European Urology Supplements. Feb2012, Vol. 11 Issue 1, pe1094-e1094a. 2p.

486 - Features of prostate cancers detected by MRI in the PSA range 1.8-2.99: A report from the Gothenburg 2 prostate cancer screening study.

Authors: Hugosson, J. Geterud, K. Arnsrud Godtman, R. et al.

Source: European Urology Supplements. Mar2018, Vol. 17 Issue 2, pe702-e702. 1p.